Inclusion Criteria:  18 years old or older, diagnosed with latent TB and determined to be appropriate for latent TB treatment by participants clinicians reside in Baltimore metro area speaks English or Spanish, or a language for which there is a short form available via the Johns Hopkins Medicine Institutional Review Board prescribed 3 months Isoniazid/Rifapentine, prescribed 3 months Isoniazid/Rifampin, or 4 months Rifampin  Exclusion Criteria:  younger than 18 years old diagnosed with active TB prescribed an alternative treatment regimen for latent TB pregnant women (as determined by non-study directed clinical evaluation; BCHD performs urine pregnancy testing on women of child bearing age when indicated) participant's spoken language does not have a translated long or short consent form